Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

10.6K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.6K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Complementation Tests00:49

Complementation Tests

4.9K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
4.9K
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

208
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
208
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal Tubular Epithelial Cells as Central Hubs of Kidney Disease.

Diagnostics (Basel, Switzerland)·2026
Same author

Special Issue: "Molecular Mechanisms and Regulation in Chronic Kidney Diseases".

International journal of molecular sciences·2026
Same author

The Ethical Aspects of AI in Scientific Publishing.

EJIFCC·2026
Same author

Pharmacological treatment of presbyopia.

Acta clinica Belgica·2026
Same author

Validation study of the Helena V8 UltraCE capillary elecrophoresis analyser.

Clinical chemistry and laboratory medicine·2026
Same author

Clinical Characteristics, Symptoms, and Long-Term Outcomes in Gitelman Syndrome.

Kidney international reports·2025

Related Experiment Video

Updated: May 5, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.4K

Complement C3 and its polymorphism: biological and clinical consequences.

Joris R Delanghe1, Reinhart Speeckaert, Marijn M Speeckaert

  • 11Departments of Clinical Chemistry 2Dermatology 3Nephrology, Ghent University Hospital, Ghent, Belgium.

Pathology
|December 5, 2013
PubMed
Summary

Complement 3 (C3) plays a key role in immunity. This review summarizes C3 characteristics and the clinical impact of C3 polymorphisms, particularly C3F and C3S variants.

More Related Videos

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

6.9K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

5.3K

Related Experiment Videos

Last Updated: May 5, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.4K
Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

6.9K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

5.3K

Area of Science:

  • Immunology
  • Genetics
  • Evolutionary Biology

Background:

  • Complement 3 (C3) is vital for innate immunity, pathogen detection, and clearance.
  • C3 polymorphism is extensively studied, with variants like C3F and C3S.
  • The C3 protein is ancient, existing in echinoderms and tunicates for over 700 million years.

Purpose of the Study:

  • To review the general characteristics and analytical aspects of C3.
  • To summarize current knowledge on the biological and clinical consequences of C3 polymorphism.
  • To highlight the functional differences between C3S and C3F variants and their disease associations.

Main Methods:

  • Literature review of studies on C3 characteristics.
  • Analysis of research on C3 polymorphism and its clinical implications.
  • Synthesis of data on C3F and C3S allele associations with disease states.

Main Results:

  • The C3F allele is generally associated with detrimental health outcomes.
  • Functional differences between C3S and C3F variants require further elucidation.
  • C3 polymorphism has significant biological and clinical relevance.

Conclusions:

  • C3 is a critical immune component with ancient evolutionary origins.
  • C3 polymorphism, especially the C3F allele, has notable clinical consequences.
  • Further research is needed to fully understand C3 variant functions and disease links.